Fifteen patients receiving standard thyroxine replacement therapy (100-200 Rtg daily) for primary hypothyroidism and who had persistently raised free thyroxine concentrations in their serum were investigated to see whether the dose being given was too high. In addition to the usual thyroid hormone assays systolic time intervals (which indicate left ventricular contractility) were calculated as accurate reflectors of tissue thyroid activity.
Introduction
It is well recognised that many hypothyroid patients receiving L-thyroxine replacement therapy have raised serum thyroxine concentrations and a raised free thyroxine index but normal serum triiodothyronine values, and the general consensus has been that such patients appear clinically euthyroid.1-4 Reports of normal thyrotrophic hormone responsiveness to thyrotrophin releasing hormone in these patients with high circulating thyroxine concentrations5 would be in keeping with this clinical impression, whereas contradictory reports of a flat thyrotrophic hormone response to releasing hormone in such subjects6 7 favour the existence of iatrogenic hyperthyroidism.
Clearly the question is whether increases of both the serum thyroxine concentration and the free thyroxine index in a patient receiving thyroxine replacement indicate that the dose being administered is in excess of that patient's physiological requirement. The emergence of systolic time intervals ( Subsequently seven of these patients were reinvestigated after reduction of their thyroxine dose.
Patients and methods
We studied 15 patients aged 26-65 years with primary hypothyroidism, who were taking 100-200 ,ug thyroxine sodium a day but no other medication. All gave informed consent. All the patients had been taking a constant dose of thyroxine for over six months and had persistently been shown to have raised free thyroxine concentrations (greater than 23 pmol/l (18 ng/100 ml)). None had evidence of any Systolic time intervals (STI) and circulating thyroxine (T4), triiodothyronine (T3), free thyroxine, free triiodothyronine, and thyrotrophic hormone (TSH) concentrations in patients with primary hypothyroidism receiving thyroxine replacement therapy 
Results
The table gives the initial results in the 15 patients ranked in order of their mean free thyroxine values. In keeping with the main criterion for selection of patients the mean free thyroxine concentration was raised at 31 2 (SD 8 2) pmol/l (2 4 (SD 0-6) ng/100 ml) (mean normal value 16 0 (4-5) pmol/l (1-2 (0 3) ng/100 ml); p< 0 0005), and similarly the mean total thyroxine value was significantly raised at 193-7 (42-2) nmol/l (15-1 (3 3) ug/lOO ml) (mean normal value 98 0 (29-3) nmol/l (7-6 (2 3) ugllOO ml); p<0 0005). By contrast, both mean total triiodothyronine (1-7 (0-3) nmol/l; 1 1 (0 2) ng/ml) and mean free triiodothyronine values (6-0 (1-1) pmol/l; 3 9 (0-7) pg/ ml) were not significantly different from their respective mean normal values (1 6 (0 6) nmol/l (1 0 (0 4) ng/ml); 5-9 (2 0) pmol/l (3-8 (1-3) pg/ ml)). The mean reverse triiodothyronine concentration was raised at 0-64 (0 26) nmol/l (0 4 (0 17) ng/ml) (mean normal value 0-34 (0 13) nmol/l (0-22 (0 08) ng/ml); p<00005). The mean systolic time interval ratio of all subjects studied was significantly reduced at 0 25 (SD 0-02) (mean normal value 0 29 (0 02); p<0 0005). In nine of the 11 subjects studied the thyrotrophic hormone response to thyrotrophin releasing hormone was flat (peak/basal value <2), whereas in the remaining two subjects the serum thyrotrophic hormone conCentration rose normally on stimulation by releasing hormone.
In the seven patients reinvestigated after a reduction in their thyroxine replacement dosage the mean serum thyroxine concentration fell from 212 (SD 45) to 162 (35) nmol/l (16-5 (3-5) to 12-6 (2-7) ug/100 ml) (p<00025), mean serum triiodothyronine concentration fell from 1 8 (0-2) to 13 (0-3) nmol/l (1-2 (0-1) to 0-8 (0-2) ng/ml) (p<0 0025), and mean systolic time interval ratio increased from 0 25 (0-02) to 0 28 (0-03) (p<00025). All seven subjects were clinically euthyroid and symptom free after the reduction of their thyroxine dosage.
Discussion
Our results confirm that in patients with primary hypothyroidism who had raised serum thyroxine and free thyroxine concentrations while receiving standard thyroxine replacement therapy, circulating concentrations of triiodothyronine and free triiodothyronine were within their respective normal ranges, whilst reverse triiodothyronine values were raised. The mean systolic time intervals of the subjects were significantly reduced as compared with normal, thus falling into the thyrotoxic range. Of the 11 patients tested with thyrotrophin releasing hormone, nine exhibited a flat response of thyrotrophic hormone, the remaining two having normal responsiveness.
We subsequently reinvestigated seven of the original patients after reducing their thyroxine replacement therapy by 50 ,±g.
The mean thyroxine concentration fell but remained just above the upper limit of normal. Alternatively we may be witnessing a direct effect of raised thyroxine concentrations. Interestingly, two subjects had normal thyrotrophic hormone responses to releasing hormone despite high circulating thyroxine concentrations, which may reflect unsuppressible thyrotrophic hormone drive. '2 We conclude that in patients with primary hypothyroidism receiving thyroxine replacement therapy a raised circulating thyroxine value may be indicative of tissue thyrotoxicosis and should prompt the lowering of the thyroxine dose.
We thank Caroline Parker for typing the manuscript. Successful plasma exchange in type 1 leprosy reversal reaction F LUCHT, G RIFLE, H PORTIER, J M CHALOPIN, J BONHOMME Abstract A 24 year old man admitted to hospital with borderline lepromatous leprosy was treated with rifampicin, dapsone, and clofazimine. After four months he developed a reversal reaction and the diagnosis was modified to borderline tuberculoid leprosy. The dose of clofazimine was raised and prednisolone added to the regimen without any symptomatic response. His condition improved dramatically after five plasma exchanges on five successive days.
Introduction
The clinical features of leprosy may alter as the patient's immune response to the disease alters. An increase in immunity -termed reversal-is common after treatment, and the disease moves towards the tuberculoid pole. In the type 1 leprosy reversal reaction severe nerve lesions may occur' and are usually controlled by clofazimine and steroids. The failure of this combination in one patient led us to try plasma exchanges. After four months' treatment with rifampicin 600 mg, dapsone 100 mg, and clofazimine 100 mg daily he developed increasing oedema, erythema, pain in the pre-existing lesions, and swelling of the affected nerves with diminution of their motor function. Temperature was 38-5°C. A scraping of the nasal mucosa yielded negative results. Circulating immune complexes were absent. A type 1 leprosy reversal reaction was confirmed by skin biopsy: histopathological examination of a thigh lesion showed a focalised histiocytic granuloma in the middle and deep layers of the dermis, with in the upper layers epithelioid cells, sometimes organised in follicles. Viable acid fast bacilli were less numerous. Borderline tuberculoid leprosy was diagnosed.
On 7 January 1984 the dosage of clofazimine was increased to 400 mg daily and prednisolone 1 mg/kg was introduced; dosages of rifampicin and dapsone remained as before. His condition did not improve, and the lesions remained painful. From 25 January, on five successive days, he was given five plasma exchanges. At each procedure 150% of theoretical plasma volume was exchanged for diluted albumin. On the third day his temperature was normal, and by the sixth day the oedema had resolved and the pain disappeared. Nerve paralysis was only slightly improved. Despite antibiotics, clofazimine, and steroids, which were continued in unaltered dosage until 10 March, on 17 February he developed a second, identical type 1 leprosy reversal reaction. Plasma exchange as before had a similar effect, after which his condition continued to improve.
Discussion
Plasma exchange has been used successfully in type 2 reactions (erythema nodosum leprosum) resulting from deposition of immune complexes,2 but to our knowledge it has never been used in type 1 reactions. Although results in a single case must be interpreted carefully, such a close relation between plasma exchange and clinical improvement suggests a causal relation.
Usually type 1 leprosy reversal reactions are controlled by clofazimine and steroids. The failure of these drugs in this case may have been due to the fact that rifampicin and dapsone were given in high dosages for a long period. In type 1 leprosy reversal reactions there is an increased phytohaemagglutinin lymphocyte response, which might be explained by a decrease in mycobacterial load in macrophages due to effective antileprosy
